Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-small Cell Lung Cancer Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02182232
What this trial is testing

A Dose Escalation Study of BIBF 1120 Together With Paclitaxel and Carboplatin in Patients With Advanced Stage Non-small-cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 33
Testing effectiveness (Phase 2)Study completedNCT00622193
What this trial is testing

Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Helsinn Therapeutics (U.S.), Inc 228
Testing effectiveness (Phase 2)Ended earlyNCT03827850
What this trial is testing

FGFR Inhibitor in FGFR Dysregulated Cancer

Who this might be right for
Lung CancerNSCLCPulmonary Neoplasm+2 more
Lung Cancer Group Cologne 22
Testing effectiveness (Phase 2)Study completedNCT04997382
What this trial is testing

Chemotherapy Combined with ICIs in First-line Alectinib Failed Patients with ALK-rearranged NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Hunan Province Tumor Hospital 112
Testing effectiveness (Phase 2)UnknownNCT03693326
What this trial is testing

PDR001 in Patients With Non-small Cell Lung Cancer Harboring KRAS/NRAS Mutation or no Actionable Genetic Abnormalities

Who this might be right for
CancerLung Cancer MetastaticImmunotherapy
Asan Medical Center 70
Early research (Phase 1)Study completedNCT00004225
What this trial is testing

Gene Therapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Looking for participantsNCT06868485
What this trial is testing

Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Wayshine Biopharm, Inc. 40
Not applicableWithdrawnNCT05116618
What this trial is testing

Detection of Resistance Mechanisms in Cerebrospinal Fluid for EGFR-mutant, ALK- and ROS1-rearranged

Who this might be right for
Non-Small Cell Lung Cancer
University of Colorado, Denver
Testing effectiveness (Phase 2)UnknownNCT03424759
What this trial is testing

Uncommon EGFR AZD9291

Who this might be right for
Non Small Cell Lung Cancer
Samsung Medical Center 37
Testing effectiveness (Phase 2)UnknownNCT01240525
What this trial is testing

Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
University College, London 114
Testing effectiveness (Phase 2)Looking for participantsNCT04302025
What this trial is testing

Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Genentech, Inc. 99
Testing effectiveness (Phase 2)Study completedNCT02733250
What this trial is testing

Pembrolizumab With Nab-Paclitaxel in Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Centre hospitalier de l'Université de Montréal (CHUM) 10
Testing effectiveness (Phase 2)Study completedNCT02031458
What this trial is testing

Atezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 667
Not applicableStudy completedNCT00898417
What this trial is testing

Biomarker Study of Blood Samples From Patients With Non-Small Cell Lung Cancer Treated With Carboplatin and Paclitaxel With or Without Bevacizumab

Who this might be right for
Lung Cancer
ECOG-ACRIN Cancer Research Group 90
Testing effectiveness (Phase 2)Study completedNCT00085813
What this trial is testing

Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer
GlaxoSmithKline 70
Large-scale testing (Phase 3)Study completedNCT02366143
What this trial is testing

Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Hoffmann-La Roche 1,202
Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Large-scale testing (Phase 3)Active Not RecruitingNCT04765059
What this trial is testing

Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 98
Early research (Phase 1)Study completedNCT02526017
What this trial is testing

Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers

Who this might be right for
Advanced Solid TumorsHead and Neck CancerPancreatic Cancer+4 more
Five Prime Therapeutics, Inc. 313
Testing effectiveness (Phase 2)Ended earlyNCT00359450
What this trial is testing

Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer)

Who this might be right for
Non-small Cell Lung Cancer
Bristol-Myers Squibb 186
Next Page